• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: November 8-14, 2009

The FDA Public Calendar contains reports of meetings held by FDA policy makers with persons outside the executive branch of the Federal government.

November 9-14, 2009

 

FDA Official and Title

 

Date

 

Location

 

Other FDA Participants

 

Non-FDA Participants

 

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 11/9/09 San Francisco, CA N/A N/A Speech at Burrill & Co’s 5th Annual Personalized Medicine Meeting
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 11/12/09 New York, NY George Strait N/A 2009 Reuters Health Summit
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs 11/13/09 Silver Spring, MD Jeff Farrar, Jeanne Ireland, Stephen Sundlof, Leslye Fraser, Mike Landa, Howard Levine, Michael Chappell, Kristy Moran

Erik Olson, Sandy Eskin, (The Pew Charitable Trusts) Carolyn Smith DeWaal, David Plunkett, (Center for Science and the Public Interest) Ami Gadhia, Ellen Bloom, Jean Halloran, (Consumers Union) Carol Tucker Forman, Chris Waldrop, (Consumer Federation of America) Tony Corbo, (Food and Water Watch) Nancy Donley, Donna Rosenbaum, (Safe Tables Our Priority) Pat Buck, (Center for Foodborne Illness Research and Protection) Dara Lieberman, (Trust for America's Health) Courtney Brein, (National Consumers League)

 

Food Safety Legislation
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/9/09 Philadelphia, PA Lawrence Deyton, Mike Cummings, Mitch Zeller N/A APHA Annual Meeting and Expo
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/10/09 Washington, DC Jeanne Ireland, Mike Taylor Senator Mary Landrieu, Senator David Vitter Oyster Regulation
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/12/09 Silver Spring, MD Afia Asamoah, Lee Zwanziger, Nancy Ostrove N/A Risk Communication Advisory Committee and Transparency Task Force 
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/12/09 Washington, DC N/A Peter Saltonstall, (NORD) Meeting with BOD of NORD
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/12/09 Washington, DC N/A Kathleen Jaeger, (GPhA) Annual GPhA CEO Summit 
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/12/09 Baltimore, MD N/A Ed Helton, (NCI) CDISC and the Public Health
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs 11/14/09 Nashville, TN N/A N/A PRIM&R Advancing Ethical Research Conference
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health 11/9/09-11/13/09 N/A N/A N/A No Significant Meetings
Russell Abbott, Acting Deputy Commissioner for Administration and Chief Financial Officer 11/9/09 - 11/13/09 N/A N/A N/A No Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs 11/10/09 Rockville, MD Jill Warner, Laurie Lenkel, Margaret Renner Denis Barritault, (OTR3) Jeffery Davidson, (Vanderbilt University School of Medicine) David Rosen, (Foley & Lardner LLP) Philippe Gadal, John Ferreira, (Regenskin) Product Designation Issue
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget 11/11/09 Washington, DC  N/A Catherine Cohen, (American Academy of Ophthalmology) Nancy Myers, (Catalyst Healthcare Consulting) Vision for FDA 
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research 11/12/09 Bethesda, MD Gerald DalPan Thomas Scarnecchia, (Executive Director, OMOP) Shawn Murphy, (Medical Director, Research Computing, Partners Healthcare) Ronald Krall, (Former Senior Vice President and Chief Medical Officer, GlaxoSmithKline)   Observational Medical Outcomes Partnership 
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs 11/9/09-11/13/09 N/A N/A N/A No Significant Meetings 
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research 11/9/09-11/13/09 N/A N/A N/A No Significant Meetings
Jeffrey Shuren, M.D., J.D., Acting Director, Center for Devices and Radiological Health 11/9/09 Silver Spring, MD Nancy Stade, Alberto Gutierrez, Elizabeth Mansfield Mary Pendergast, (Pendergast Consulting) Medical Devices
Jeffrey Shuren, M.D., J.D., Acting Director, Center for Devices and Radiological Health 11/13/09 Silver Spring, MD N/A Navjot Singh, Chris Simon, Deep Shenoy, (McKinsey Group) Medical Devices
Stephen Sundlof, D.V.M., P.h.D., Director, Center for Food Safety and Applied Nutrition 11/12/09 College Park, MD Faye Feldstein, Don Kraemer, Jon Woody, Marion Allen, Jason Bashura, LeeAnne Jackson Michael Moody, Thomas Tucker, Jim Fernandez, (LSU National Center for Biomedical Research) Overview of  Future Research in Food Defense  Needs
Bernadette Dunham, D.V.M., P.h.D., Director, Center for Veterinary Medicine 11/10/09 Rockville, MD William Flynn, Tracey Forfa, Dan McChesney, Nadine Steinberg, Linda Benjamin, Michaela Alewynse, Barry Hooberman, Janice Steinschneider Michael Giambalvo, Richard Coulter, Paul Duquette, Kristy Smedley, Martin Hahn, (Phibro Animal Health) Policy and regulations
Bernadette Dunham, D.V.M., P.h.D., Director, Center for Veterinary Medicine 11/12/09 Rockville, MD Aila Albrecht, Karen Ekelman, Jeff Gilbert, Barry Hooberman, Laura Hungerford, Ruby Singh, Steve Vaughn, Dave White Tony Cox, (Cox Associates and King Pharmaceuticals) Drug approval process
Bernadette Dunham, D.V.M., P.h.D., Director, Center for Veterinary Medicine 11/13/09 Rockville, MD Steve Vaughn Sandy Flick, Doug Rupp, (Alpharma) Drug approval process
William Slikker, Jr., P.h.D., Director, National Center for Toxicological Research 11/12/09 Jefferson, AR Jeanne Anson, Jennings Partridge Mary Amann, Colonel Franz J. Amann (DOD) Overview and tour of NCTR facility
Michael M. Landa, J.D., Acting Chief Counsel 11/9/09-11/13/09 N/A N/A N/A No Significant Meetings
Lawrence Deyton, M.D., M.P.H., Director, Center for Tobacco Products 11/9/09 Philadelphia, PA N/A Registered Attendees APHA Session:  FDA Regulation of Tobacco Products